8178

Información básica

• Disponible en:
• Español
• English

Product Description:

The EarlyTect Colon Cancer Test is a groundbreaking product in the field of colorectal cancer detection. It has been meticulously developed and clinically tested at esteemed institutions such as Yonsei Medical Center, Severance Hospital, and Severance Check-up Center in Korea. Approved by the Korea Ministry of Food and Drug Safety, this test has undergone rigorous clinical trials involving 585 men and women aged 30 to 80.

Using fecal DNA analysis, the EarlyTect Colon Cancer Test has demonstrated an impressive 90% sensitivity and specificity in diagnosing colorectal cancer. This qualitative real-time PCR test specifically measures the levels of methylated Syndecan-2, a biomarker that is clinically associated with precancerous lesions of colorectal cancer. It should be noted that this test is not intended to provide a confirmation of colorectal cancer. However, if a subject tests positive, it indicates the potential presence of colorectal cancer or precancerous lesions of colorectal cancer.

Product Standard:

- Cancer Type: Colorectal Cancer
- Target Subject: Asymptomatic individuals undergoing colorectal cancer screening
- Biomarker: Methylated Syndecan-2 (SDC2 me)

Please note that the price and transaction conditions for this product are negotiable. To proceed with the purchase, we kindly request you to submit a quote through our website or contact our sales team directly.

We hope that the EarlyTect Colon Cancer Test will contribute to early detection and ultimately save lives in the fight against colorectal cancer.